title: American Cancer Society prostate cancer survivorship care guidelines.
abstract: Prostate cancer survivors approach 2.8 million in number and represent 1 in 5 of all cancer survivors in the United States. While guidelines exist for timely treatment and surveillance for recurrent disease, there is limited availability of guidelines that facilitate the provision of posttreatment clinical follow-up care to address the myriad of long-term and late effects that survivors may face. Based on recommendations set forth by a National Cancer Survivorship Resource Center expert panel, the American Cancer Society developed clinical follow-up care guidelines to facilitate the provision of posttreatment care by primary care clinicians. These guidelines were developed using a combined approach of evidence synthesis and expert consensus. Existing guidelines for health promotion, surveillance, and screening for second primary cancers were referenced when available. To promote comprehensive follow-up care and optimal health and quality of life for the posttreatment survivor, the guidelines address health promotion, surveillance for prostate cancer recurrence, screening for second primary cancers, long-term and late effects assessment and management, psychosocial issues, and care coordination among the oncology team, primary care clinicians, and nononcology specialists. A key challenge to the development of these guidelines was the limited availability of published evidence for management of prostate cancer survivors after treatment. Much of the evidence relies on studies with small sample sizes and retrospective analyses of facility-specific and population databases.
authors.affiliation: Assistant Professor of Urology, Department of Urology, University of Michigan, Research Investigator, HSR&D Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI.
authors.forename: Ted A
authors.initials: TA
authors.lastname: Skolarus
authors.forename: Andrew M D
authors.initials: AM
authors.lastname: Wolf
authors.forename: Nicole L
authors.initials: NL
authors.lastname: Erb
authors.forename: Durado D
authors.initials: DD
authors.lastname: Brooks
authors.forename: Brian M
authors.initials: BM
authors.lastname: Rivers
authors.forename: Willie
authors.initials: W
authors.lastname: Underwood
authors.forename: Andrew L
authors.initials: AL
authors.lastname: Salner
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Zelefsky
authors.forename: Jeanny B
authors.initials: JB
authors.lastname: Aragon-Ching
authors.forename: Susan F
authors.initials: SF
authors.lastname: Slovin
authors.forename: Daniela A
authors.initials: DA
authors.lastname: Wittmann
authors.forename: Michael A
authors.initials: MA
authors.lastname: Hoyt
authors.forename: Victoria J
authors.initials: VJ
authors.lastname: Sinibaldi
authors.forename: Gerald
authors.initials: G
authors.lastname: Chodak
authors.forename: Mandi L
authors.initials: ML
authors.lastname: Pratt-Chapman
authors.forename: Rebecca L
authors.initials: RL
authors.lastname: Cowens-Alvarado
mesh_terms: D000570:American Cancer Society; D003266:Continuity of Patient Care / Q000592:standards*; D019317:Evidence-Based Medicine; D006293:Health Promotion / Q000592:standards; D006801:Humans; D008297:Male; D011159:Population Surveillance; D011320:Primary Health Care / Q000592:standards*; D011471:Prostatic Neoplasms / Q000628:therapy*; D011788:Quality of Life; D017741:Survivors; D014481:United States
keywords: care coordination; clinical care; follow-up; guidelines; late effects; long-term effects; primary care; prostate cancer; quality of life; survivorship; survivorship care plan